Cabot Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Cabot heeft de winst zien groeien met een gemiddeld jaarlijks percentage van 16%, terwijl de Chemicals-industrie de winst zag dalen met 2.9% per jaar. De inkomsten zijn gedaald met een gemiddeld jaarlijks percentage van 0.2%. Het rendement op eigen vermogen van Cabot is 13.1%, en het heeft een nettomarge van 5.1%.
Belangrijke informatie
15.97%
Groei van de winst
17.10%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.93% |
| Inkomstengroei | -0.19% |
| Rendement op eigen vermogen | 13.15% |
| Nettomarge | 5.15% |
| Laatste winstupdate | 30 Jun 2026 |
Recente prestatie-updates uit het verleden
Recent updates
Narratiefupdate • Aug 16
CBT: Rising Carbon Black Concerns Will Drive A Weaker Future Profile
Cabot's analyst price target has moved up from $70.37 to $78.00, with analysts pointing to updated views on revenue growth, profitability, and P/E assumptions following recent research that includes higher price objectives of $90 and $100, along with positive commentary on the battery materials and Performance Chemicals businesses. Analyst Commentary Recent research on Cabot has centered on how the stock trades relative to its P/E assumptions and perceived growth potential in key businesses such as battery materials and Performance Chemicals.Seeking Alpha • Aug 04
Cabot Corporation: Successful Returns, Downgrading Into 2027-2028E (Downgrade)
Summary Cabot Corporation is now fairly valued after a period of significant undervaluation and strong operational outperformance. I downgrade CBT to Hold with a new price target of $82/share, as the current upside is limited following a 20-30% rally. CBT’s disciplined capital allocation, low leverage, and resilient margins underpin its stability despite cyclical end-market pressures. Future growth hinges on recovery in reinforcement materials and continued strength in performance chemicals, but macro risks constrain further upside. Read the full article on Seeking AlphaNieuw narratief • Aug 02
Battery Materials Competition And Cost Pressures Will Limit Long-Term Earnings Potential
Catalysts About Cabot Cabot Corporation produces specialty chemicals and materials including reinforcement materials, performance chemicals and battery materials that serve a range of industrial and energy storage applications. What are the underlying business or industry changes driving this perspective?
Narratiefupdate • Jun 26
CBT: Battery Materials And Buybacks Will Shape Balanced Medium-Term Outlook
Analysts have nudged their fair value estimate for Cabot higher to $88.50 from $85.67, citing updated price targets in the $70 to $98 range and renewed attention on the company’s battery materials, Reinforcement Materials, and Performance Chemicals businesses. Analyst Commentary Recent Street commentary on Cabot gives a mixed but useful read on how professionals are weighing the company’s earnings potential, valuation, and execution across its key segments, especially battery materials, Reinforcement Materials, and Performance Chemicals.
Nieuw narratief • Jun 23
Battery And Data Center Demand Will Drive Long-Term Upside Potential
Catalysts About Cabot Cabot develops specialty materials, including reinforcement and performance chemicals used across tires, batteries and broader industrial applications. What are the underlying business or industry changes driving this perspective?Analyse-artikel • Jun 21
Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating
Cabot (CBT) has drawn fresh attention after receiving a platinum rating from EcoVadis for the sixth consecutive year, placing the company among the top 1% of peers in environmental, social, and governance practices. See our latest analysis for Cabot. The EcoVadis recognition has arrived during a strong run in Cabot’s stock, with a 34.09% 3 month share price return and a 28.47% 1 year total shareholder return, which may indicate building momentum rather than a short lived spike. If Cabot’s...Nieuw narratief • Jun 09
Battery And Data Center Demand Will Support A Steady Long Term Materials Story
Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?Analyse-artikel • Nov 03
Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?
While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...Analyse-artikel • Sep 11
Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch
With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...Analyse-artikel • Jul 20
Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?
Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...Analyse-artikel • Jun 23
Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns
There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...Analyse-artikel • Apr 25
These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyse-artikel • Apr 10
Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price
Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...Analyse-artikel • Mar 12
A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price
Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...Seeking Alpha • Feb 13
Cabot Corporation: Reinforcing Positive Shareholder Value
Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking AlphaSeeking Alpha • Jan 30
Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)
Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking AlphaAnalyse-artikel • Jan 29
Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?
Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...Analyse-artikel • Jan 15
Is Cabot (NYSE:CBT) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyse-artikel • Jan 02
Returns On Capital Are A Standout For Cabot (NYSE:CBT)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analyse-artikel • Dec 06
Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...Seeking Alpha • Nov 14
Cabot: Less Than 5% Annualized Upside
Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking AlphaAnalyse-artikel • Oct 31
Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analyse-artikel • Oct 19
Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?
Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...Opbrengsten en kosten
Opbrengsten en kosten
Hoe Cabot geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 26 | 3,634 | 187 | 270 | 54 |
| 31 Mar 26 | 3,575 | 281 | 259 | 56 |
| 31 Dec 25 | 3,607 | 306 | 257 | 56 |
| 30 Sep 25 | 3,713 | 326 | 255 | 57 |
| 30 Jun 25 | 3,815 | 418 | 263 | 60 |
| 31 Mar 25 | 3,908 | 426 | 270 | 61 |
| 31 Dec 24 | 3,991 | 417 | 281 | 62 |
| 30 Sep 24 | 3,994 | 374 | 282 | 63 |
| 30 Jun 24 | 3,958 | 470 | 280 | 60 |
| 31 Mar 24 | 3,910 | 443 | 269 | 59 |
| 31 Dec 23 | 3,924 | 433 | 260 | 59 |
| 30 Sep 23 | 3,931 | 437 | 254 | 57 |
| 30 Jun 23 | 4,078 | 300 | 242 | 57 |
| 31 Mar 23 | 4,259 | 315 | 237 | 58 |
| 31 Dec 22 | 4,318 | 348 | 246 | 55 |
| 30 Sep 22 | 4,321 | 206 | 255 | 55 |
| 30 Jun 22 | 4,113 | 142 | 290 | 56 |
| 31 Mar 22 | 3,881 | 130 | 306 | 56 |
| 31 Dec 21 | 3,631 | 98 | 297 | 55 |
| 30 Sep 21 | 3,409 | 247 | 293 | 56 |
| 30 Jun 21 | 3,164 | -54 | 315 | 57 |
| 31 Mar 21 | 2,765 | -144 | 296 | 54 |
| 31 Dec 20 | 2,633 | -219 | 292 | 57 |
| 30 Sep 20 | 2,614 | -238 | 295 | 57 |
| 30 Jun 20 | 2,782 | 65 | 246 | 54 |
| 31 Mar 20 | 3,109 | 103 | 261 | 57 |
| 31 Dec 19 | 3,243 | 127 | 268 | 58 |
| 30 Sep 19 | 3,337 | 155 | 270 | 60 |
| 30 Jun 19 | 3,360 | 217 | 281 | 65 |
| 31 Mar 19 | 3,369 | 273 | 282 | 66 |
| 31 Dec 18 | 3,343 | 77 | 295 | 67 |
| 30 Sep 18 | 3,242 | -114 | 295 | 66 |
| 30 Jun 18 | 3,115 | -136 | 282 | 64 |
| 31 Mar 18 | 2,966 | -177 | 279 | 61 |
| 31 Dec 17 | 2,826 | 69 | 263 | 59 |
| 30 Sep 17 | 2,717 | 246 | 258 | 57 |
| 30 Jun 17 | 2,613 | 225 | 270 | 53 |
| 31 Mar 17 | 2,529 | 234 | 269 | 51 |
| 31 Dec 16 | 2,419 | 209 | 264 | 49 |
| 30 Sep 16 | 2,411 | 145 | 266 | 48 |
| 30 Jun 16 | 2,463 | 136 | 251 | 49 |
| 31 Mar 16 | 2,536 | -366 | 256 | 52 |
| 31 Dec 15 | 2,662 | -388 | 263 | 54 |
| 30 Sep 15 | 2,871 | -336 | 271 | 58 |
Kwaliteitswinsten: CBT heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (5.1%) CBT } zijn lager dan vorig jaar (11%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: CBT is de afgelopen 5 jaar winstgevend geworden en heeft de winst met 16% per jaar laten groeien.
Versnelling van de groei: De winstgroei CBT is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.
Winst versus industrie: CBT had het afgelopen jaar een negatieve winstgroei ( -55.3% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Chemicals ( 2.4% ).
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 13.1% ) van CBT wordt als laag beschouwd.
Rendement op activa
Rendement op geïnvesteerd vermogen
Ontdek sterk presterende bedrijven uit het verleden
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/15 13:33 |
| Aandelenkoers aan het einde van de dag | 2026/09/15 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/09/30 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Cabot Corporation wordt gevolgd door 11 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Benjamin Kallo | Baird |
| Michael Leithead | Barclays |
| David Begleiter | Deutsche Bank |